Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Income Statement [Abstract]    
Net Sales $ 5,914
Operating Expenses:    
Research and development 375,220 257,803
General and administrative 4,327,529 2,873,185
Total operating expenses (4,702,749) (3,130,988)
Loss from operations (4,696,835) (3,130,988)
Other income (expense)    
Other income 20,099 52,898
Change in fair value of derivative liability 5,900
Debt extinguishment (977,203) (455,975)
Financing costs (643,481)
Interest expense (including $235,798 and $232,076 to related parties) (555,094) (340,580)
Interest expense - amortization of debt discount (418,339) (398,594)
Total other expense (2,568,118) (1,142,251)
Loss before income tax provision (7,264,953) (4,273,239)
Income tax provision 1,600 866
Net loss $ (7,266,553) $ (4,274,105)
Loss per share - basic and diluted $ (0.07) $ (0.05)
Weighted average number of common shares outstanding - basic and diluted 106,148,101 79,602,170